ARCA biopharma, Inc. Gains 90.06%

Wed, Apr 03, 2024 at 07:15 PM
ARCA biopharma, Inc. Gains 90.06%

ARCA biopharma, Inc. (ABIO:NASDAQ) jumped higher at $3.25, representing a gain of 90.1%. On Wed, Apr 03, 2024, ABIO:NASDAQ hit a New 2-Week High of $3.25. The stock got featured on our News Catalysts scanner on Wed, Apr 03, 2024 at 02:13 PM in the 'MERGER' category. From Wed, Mar 20, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days

About ARCA biopharma, Inc. (ABIO:NASDAQ)

ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.